Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders

Journal of Pharmaceutical Sciences

Volumn 100, Issue 9, 2011, Pages 3594-3601

  Hara, Takafumi ^a   Hirasawa, Akira ^a   Ichimura, Atsuhiko ^a   Kimura, Ikuo ^a   Tsujimoto, Gozoh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Gastrointestinal; Hormones; Lipids; Metabolism; Receptors

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CALCIUM ION; DOCOSAHEXAENOIC ACID; EPOXYICOSATRIENOIC ACID; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; GLUCOSE; GRIFOLIC ACID; GW 9508; INSULIN; LIGAND; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG TARGETING; GENETIC VARIABILITY; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE FUNCTION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; METABOLIC DISORDER; NONHUMAN; PANCREAS ISLET BETA CELL; PERITONEUM MACROPHAGE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

EID: 80955180014     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22639     Document Type: Review

References (58)

1. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. 2001. Nuclear receptors and lipid physiology: Opening the X-files. Science 294(5548):1866-1870.
2. Sauer LA, Dauchy RT, Blask DE. 2000. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res 60(18):5289-5295.
3. Louet JF, Chatelain F, Decaux JF, Park EA, Kohl C, Pineau T, Girard J, Pegorier JP. 2001. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem J 354(Pt 1):189-197.
4. Civelli O. 2005. GPCR deorphanizations: The novel, the known, and the unexpected transmitters. Trends Pharmacol Sci 26(1):15-19.
5. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. 2003. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13):11312-11319.
6. Nilsson NE, Kotarsky K, Owman C, Olde B. 2003. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303(4):1047-1052.
7. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M. 2003. Functional characterization of human receptors for short-chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28):25481-25489.
8. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. 2008. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149(9):4519-4526.
9. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282-1286.
10. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, Yanagisawa M. 2004. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 101(4):1045-1050.
11. Miyauchi S, Hirasawa A, Ichimura A, Hara T, Tsujimoto G. 2010. New frontiers in gut nutrient sensor research: Free fatty acid sensing in the gastrointestinal tract. J Pharmacol Sci 112(1):19-24.
12. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M. 2003. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422(6928):173-176.
13. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. 2005. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11(1):90-94.
14. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142(5):687-698.
15. Kotarsky K, Nilsson NE, Flodgren E, Owman C, Olde B. 2003. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun 301(2):406-410.
16. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, Murdock PR, Sauls HR, Shabon U, Spinage LD, Strum JC, Szekeres PG, Tan KB, Way JM, Ignar DM, Wilson S, Muir AI. 2003. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278(13):11303-11311.
17. Shapiro H, Shachar S, Sekler I, Hershfinkel M, Walker MD. 2005. Role of GPR40 in fatty acid action on the beta cell line INS-1E. Biochem Biophys Res Commun 335(1):97-104.
18. Hara T, Hirasawa A, Sun Q, Koshimizu TA, Itsubo C, Sadakane K, Awaji T, Tsujimoto G. 2009. Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1). Mol Pharmacol 75(1):85-91.
19. Fujiwara K, Maekawa F, Yada T. 2005. Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: Mediation by PLC and L-type Ca2+ channel and link to insulin release. Am J Physiol Endocrinol Metab 289(4):E670-E677.
20. Welters HJ, Diakogiannaki E, Mordue JM, Tadayyon M, Smith SA, Morgan NG. 2006. Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic beta-cells exposed to palmitate. Apoptosis 11(7):1231-1238.
21. Salehi A, Flodgren E, Nilsson NE, Jimenez-Feltstrom J, Miyazaki J, Owman C, Olde B. 2005. Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res 322(2):207-215.
22. Feng DD, Luo Z, Roh SG, Hernandez M, Tawadros N, Keating DJ, Chen C. 2006. Reduction in voltage-gated K+ currents in primary cultured rat pancreatic beta-cells by linoleic acids. Endocrinology 147(2):674-682.
23. Latour MG, Alquier T, Oseid E, Tremblay C, Jetton TL, Luo J, Lin DC, Poitout V. 2007. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes 56(4):1087-1094.
24. Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. 2005. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1(4):245-258.
25. Edfalk S, Steneberg P, Edlund H. 2008. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57(9):2280-2287.
26. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD. 1997. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100(2):398-403.
27. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT. 1998. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47(10):1613-1618.
28. Dobbins RL, Chester MW, Stevenson BE, Daniels MB, Stein DT, McGarry JD. 1998. A fatty acid-dependent step is critically important for both glucose- and nonglucose-stimulated insulin secretion. J Clin Invest 101(11):2370-2376.
29. Gravena C, Mathias PC, Ashcroft SJ. 2002. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J Endocrinol 173(1):73-80.
30. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD. 1996. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97(12):2728-2735.
31. Nagasumi K, Esaki R, Iwachidow K, Yasuhara Y, Ogi K, Tanaka H, Nakata M, Yano T, Shimakawa K, Taketomi S, Takeuchi K, Odaka H, Kaisho Y. 2009. Overexpression of GPR40 in pancreatic {beta}-cells augments glucose stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes 58(5):1067-1076.
32. Hamid YH, Vissing H, Holst B, Urhammer SA, Pyke C, Hansen SK, Glumer C, Borch-Johnsen K, Jorgensen T, Schwartz TW, Pedersen O, Hansen T. 2005. Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release. Diabet Med 22(1):74-80.
33. Ogawa T, Hirose H, Miyashita K, Saito I, Saruta T. 2005. GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men. Metabolism 54(3):296-299.
34. Vettor R, Granzotto M, De Stefani D, Trevellin E, Rossato M, Farina MG, Milan G, Pilon C, Nigro A, Federspil G, Vigneri R, Vitiello L, Rizzuto R, Baratta R, Frittitta L. 2008. Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization. J Clin Endocrinol Metab 93(9):3541-3550.
35. Bharate SB, Nemmani KV, Vishwakarma RA. 2009. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): An emerging target for type 2 diabetes. Expert Opin Ther Pat 19(2):237-264.
36. Garrido DM, Corbett DF, Dwornik KA, Goetz AS, Littleton TR, McKeown SC, Mills WY, Smalley TL Jr., Briscoe CP, Peat AJ. 2006. Synthesis and activity of small molecule GPR40 agonists. Bioorg Med Chem Lett 16(7):1840-1845.
37. Hu H, He LY, Gong Z, Li N, Lu YN, Zhai QW, Liu H, Jiang HL, Zhu WL, Wang HY. 2009. A novel class of antagonists for the FFAs receptor GPR40. Biochem Biophys Res Commun 390(3):557-563.
38. Humphries PS, Benbow JW, Bonin PD, Boyer D, Doran SD, Frisbie RK, Piotrowski DW, Balan G, Bechle BM, Conn EL, Dirico KJ, Oliver RM, Soeller WC, Southers JA, Yang X. 2009. Synthesis and SAR of 1, 2, 3, 4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists. Bioorg Med Chem Lett 19(9):2400-2403.
39. Zhang X, Yan G, Li Y, Zhu W, Wang H. 2010. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats. Biomed Pharmacother 64(9):647-651.
40. Bharate SB, Rodge A, Joshi RK, Kaur J, Srinivasan S, Kumar SS, Kulkarni-Almeida A, Balachandran S, Balakrishnan A, Vishwakarma RA. 2008. Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists. Bioorg Med Chem Lett 18(24):6357-6361.
41. Christiansen E, Urban C, Merten N, Liebscher K, Karlsen KK, Hamacher A, Spinrath A, Bond AD, Drewke C, Ullrich S, Kassack MU, Kostenis E, Ulven T. 2008. Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med Chem 51(22):7061-7064.
42. McKeown SC, Corbett DF, Goetz AS, Littleton TR, Bigham E, Briscoe CP, Peat AJ, Watson SP, Hickey DM. 2007. Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor. Bioorg Med Chem Lett 17(6):1584-1589.
43. Song F, Lu S, Gunnet J, Xu JZ, Wines P, Proost J, Liang Y, Baumann C, Lenhard J, Murray WV, Demarest KT, Kuo GH. 2007. Synthesis and biological evaluation of 3-aryl-3-(4-phenoxy)-propionic acid as a novel series of G protein-coupled receptor 40 agonists. J Med Chem 50(12):2807-2817.
44. Zhou C, Tang C, Chang E, Ge M, Lin S, Cline E, Tan CP, Feng Y, Zhou YP, Eiermann GJ, Petrov A, Salituro G, Meinke P, Mosley R, Akiyama TE, Einstein M, Kumar S, Berger J, Howard AD, Thornberry N, Mills SG, Yang L. 2010. Discovery of 5-aryloxy-2, 4-thiazolidinediones as potent GPR40 agonists. Bioorg Med Chem Lett 20(3):1298-1301.
45. Briscoe CP, Peat AJ, McKeown SC, Corbett DF, Goetz AS, Littleton TR, McCoy DC, Kenakin TP, Andrews JL, Ammala C, Fornwald JA, Ignar DM, Jenkinson S. 2006. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: Identification of agonist and antagonist small molecules. Br J Pharmacol 148(5):619-628.
46. Hara T, Hirasawa A, Sun Q, Sadakane K, Itsubo C, Iga T, Adachi T, Koshimizu TA, Hashimoto T, Asakawa Y, Tsujimoto G. 2009. Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiedebergs Arch Pharmacol 380(3):247-255.
47. Sum CS, Tikhonova IG, Costanzi S, Gershengorn MC. 2009. Two arginine-glutamate ionic locks near the extracellular surface of FFAR1 gate receptor activation. J Biol Chem 284(6):3529-3536.
48. Fukunaga S, Setoguchi S, Hirasawa A, Tsujimoto G. 2006. Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach. Life Sci 80(1):17-23.
49. Suzuki T, Igari S, Hirasawa A, Hata M, Ishiguro M, Fujieda H, Itoh Y, Hirano T, Nakagawa H, Ogura M, Makishima M, Tsujimoto G, Miyata N. 2008. Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists. J Med Chem 51(23):7640-7644.
50. Katsuma S, Hatae N, Yano T, Ruike Y, Kimura M, Hirasawa A, Tsujimoto G. 2005. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J Biol Chem 280(20):19507-19515.
51. Miyauchi S, Hirasawa A, Iga T, Liu N, Itsubo C, Sadakane K, Hara T, Tsujimoto G. 2009. Distribution and regulation of protein expression of the free fatty acid receptor GPR120. Naunyn Schmiedebergs Arch Pharmacol 379(4):427-434.
52. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F. 2009. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52(2):289-298.
53. Sidhu SS, Thompson DG, Warhurst G, Case RM, Benson RS. 2000. Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag. J Physiol 528(1):165-176.
54. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G. 2008. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 377(4-6):523-527.
55. Matsumura S, Mizushige T, Yoneda T, Iwanaga T, Tsuzuki S, Inoue K, Fushiki T. 2007. GPR expression in the rat taste bud relating to fatty acid sensing. Biomed Res 28(1):49-55.
56. Matsumura S, Eguchi A, Mizushige T, Kitabayashi N, Tsuzuki S, Inoue K, Fushiki T. 2009. Colocalization of GPR120 with phospholipase-Cbeta2 and alpha-gustducin in the taste bud cells in mice. Neurosci Lett 450(2):186-190.
57. Gotoh C, Hong YH, Iga T, Hishikawa D, Suzuki Y, Song SH, Choi KC, Adachi T, Hirasawa A, Tsujimoto G, Sasaki S, Roh SG. 2007. The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 354(2):591-597.
58. Sun Q, Hirasawa A, Hara T, Kimura I, Adachi T, Awaji T, Ishiguro M, Suzuki T, Miyata N, Tsujimoto G. 2010. Structure-activity relationships of GPR120 agonists based on a docking simulation. Mol Pharmacol 78(5):804-810.